In 258 patients with left main tract disease, the atherosclerotic risk factors were compared between patients with ostial and nonostial lesions of the left main coronary artery. Also, it was done for patients with ostial right coronary artery. Women were more likely to have ostial left main coronary artery and/or ostial right coronary artery. A multivariate logistic regression analysis revealed that the female sex (odds ratio: 2.336) and hypertriglyceridemia (odds ratio: 1.004) were independent risk factors of ostial left main coronary artery lesion. For ostial right coronary artery lesion, the female sex and family history of coronary artery disease were independent predictors. Ostial left main coronary artery and right coronary artery lesions were strongly correlated. The demographic and clinical profiles of ostial stenosis suggest that this group may represent a distinct entity, different from the more common atherosclerotic left main trunk stenosis (LMTD). The female sex and serum triglyceride level can be considered as independent predictors of ostial left main tract disease.
Murray CJL, Lopez ADThe Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Disease, Injuries and Risk Factors in 1990 and Projected to 2020. Boston, MA: Harvard School of Public Health; 1996.
2.
Sanderson BK , Bittner V.Women in cardiac rehabilitation: outcomes and identifying risk for dropout. Am Heart J. 2005;150:1052-1058.
3.
Sarraf-Zadegan N., Sayed-Tabatabaei FA, Bashardoost N., et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran . Acta Cardiol. 1999; 54:257-263.
4.
Kuulasmaa K. , Tunstall-Pedoe H., Dobson A., et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MON-ICA project populations. Lancet. 2000;355:675-687.
5.
Gyenes G., Shrive FM, Graham MM, Ghali WA, Knudtson MLThe prognostic importance of nonsignificant left main coronary artery disease in patients undergoing percutaneous coronary intervention. Am Coll Cardiol. 2006;48:276-280.
6.
Conley MJ, Ely RL, Kisslo J., Lee KL, McNeer JF, Rosati RAThe prognostic spectrum of left main stenosis. Circulation . 1978;57:947-952.
7.
Cohen MV, Gorlin R.Main left coronary artery disease clinical experience from 1964-1974 . Circulation. 1975;52:275-285.
8.
Black A., Cortina R., Bossi I., et al. Unprotected left main coronary artery stenting: Correlates of midterm survival and impact of patient selection. J Am Coll Cardiol. 2001;37:832-838.
9.
Waller BFAtherosclerotic and nonatherosclerotic factors in acute myocardial infarction . In: Pepine C, ed. Acute Myocardial Infarction. Philadelphia, PA: FA Davis Co;1989:29.
10.
Bulkley BH, Roberts WCAtherosclerotic narrowing of the left main coronary artery: a necropsy analysis of 152 patients with fatal coronary heart disease and varying degrees of left main narrowing. Circulation. 1976;53: 823-828.
11.
Dacosta A., Tardy B., Favre JP, et al. La pathologie du tronc coronaire gauche. Arch Mal Coeur. 1994;87:1225-1232.
12.
Revault d'Allonnes F., Corbineau H., Le Breton H., Leclercq C., Leguerrier A., Daubert C.Isolated left main coronary artery stenosis: long term follow up in 106 patients after surgery . Heart. 2002;87;544-548.
13.
27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events. September 14-15, 1995. J Am Coll Cardiol . 1996;27:957-1047.
14.
Saghafi H., Mahmoodi MJ, Fakhrzadeh H., Heshmat R., Shafaee A., Larijani B.Cardiovascular risk factors in first-degree relatives of patients with premature coronary artery disease. Acta Cardiol. 2006 ;61:607-613.
15.
Esteghamati A. , Abbasi M., Nakhjavani M., Yousefizadeh A., Basa AP, Afshar H.Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovasc Diabetol. 2006;17:5-15.
16.
Maddah M., Chinikar M., Hoda S.Iranian women with coronary artery disease: not behind of the men. Int J Cardiol. 2007;115:103-104.
17.
Chinikar M. , Maddah M., Hoda S.Coronary artery disease in Iranian overweight women. Int J Cardiol. 2006;113:391-394.
18.
Azizi F., Rahmani M., Emami H., et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed . 2002;47:408-426.
19.
Mahajan N., Hollander G., Malik B.Isolated and significant left main coronary artery disease: demographics, hemodynamics and angiographic features. Angiology. 2006;57:464-477.
20.
Barner HB, Reese J., Standeven J., et al. Left coronary ostial stenosis: comparison with left main coronary artery stenosis. Ann Thorac Surg. 1989;47:293-296.
21.
Sasaguri S. , Honda Y., Kanou T.Isolated coronary ostial stenosis compared with left main trunk disease. Jpn Circ J . 1991;55:1187-1191.
22.
Yamanaka O. , Hobbs RESolitary ostial coronary artery stenosis. Jpn Circ J. 1993;57:404-410.
23.
Miller GA, Honey M., el-Sayed H.Isolated coronary ostial stenosis. Cathet Cardiovasc Diagn . 1986;12:30-34.
24.
Welch CC, Proudfit WL, Sheldon WCCoronary arteriographic findings in 1,000 women under age 50. Am J Cardiol. 1975;35:211-215.
25.
Dodge JT Jr, Brown BG, Bolson EL, et al. Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation. 1992 ;86:232-246.
26.
Heggtveit HASyphilitic aortitis: a clinicopathologic autopsy study of 100 cases, 1950-1960. Circulation. 1964;29:346-355.
27.
Klein RG, Hunder GG, Stanson AW, et al. Large artery involvement in giant cell (temporal) arteritis . Ann Intern Med. 1975;83:806-812.
28.
Iga K., Gohma I., Hori K.Regression of the left main trunk lesion by steroid administration in Takayasu's aortitis. Chest. 1991;99:508-510.
29.
Yates JD, Kirsh MM, Sodeman TM, et al. Coronary ostial stenosis, a complication of aortic valve replacement . Circulation. 1974;49:530-534.
30.
Knutson EL, Smith JCCoronary ostial stenosis complicating coronary arteriography. Arch Pathol Lab Med. 1976;100:113-116.
Grollier G. , Commeau P., Mercier V., et al. Post-radiotherapeutic left main coronary ostial stenosis: clinical and histological study. Eur Heart J. 1988;9:567-570.
33.
Tenet W., Missri J., Hager D.Radiation-induced stenosis of the left main coronary artery. Cathet Cardiovasc Diagn. 1984;10:163-166.
34.
Rajtar R., Kloch M., Bober M., Kolasińska-Kloch W.The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part II. Przegl Lek. 2006;63:767-772.
35.
Puddu GM, Cravero E., Arnone G., et al. Molecular aspects of atherogenesis: new insights and unsolved questions. J Biomed Sci. 2005;12:839-853.
36.
Langheinrich AC, Bohle RMAtherosclerosis: humoral and cellular factors of inflammation. Virchows Arch. 2005 ;446:101-111.
37.
Zernecke A. , Weber C.Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol. 2005; 100:93-101.
38.
Tobias P., Curtiss LKThematic review series. The immune system and atherogenesis: paying the price for pathogen protection: toll receptors in atherogenesis. J Lipid Res. 2005;46:404-411.
39.
Manzi S., Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol. 1997;145:408-415.
40.
Solomon DH, KarlsonEW,Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107: 1303-1307.
41.
Ward MMPremature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum . 1999;42:338-346.
42.
Willerson JT , Ridker PMInflammation as a cardiovascular risk factor . Circulation. 2004;109(suppl 1):II2-II10.
43.
Jeppesen J. , Hein HO, Suadicani P.Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen male study . Circulation. 1998;97: 1029-1036.
44.
Castelli WPEpidemiology of triglycerides: a view from Framingham . Am J Cardiol. 1992;70:3H-9H.
45.
Assmann G., Schulte H., Cullen P.New and classical risk factors-the Munster heart study (PROCAM). Eur J Med Res. 1997;2:237-242.
Austin MAPlasma triglyceride as a risk factor for coronary heart disease: the epidemiologic evidence and beyond. Am J Epidemiol. 1989;129:249-259.
48.
Hokanson JE , Austin MAPlasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies . J Cardiovasc Risk. 1996;3:213-219.
